DWK Life Sciences to Acquire Müller + Müller
Müller + Müller will become part of DWK upon closing in September 2020 and will continue to function under the same name and management.
DWK Life Sciences announced on August 26, 2020 that it has acquired Müller + Müller, a German manufacturer of primary packaging materials made of tubular glass for the pharmaceutical industry.
Under the terms of the acquisition, Müller + Müller will become part of DWK upon closing in September 2020, a DWK press release said. Müller + Müller will continue to function under the same name and will be managed by its current CEO, Florian Müller-Stauch.
“Acquiring the family business Müller + Müller is a significant strategic step for us in expanding our activities in the market for pharmaceuticals packaging,” explained CEO of DWK Life Sciences, Armin Reiche, in the press release. “We are not just investing in an important growth market here, but also in a company that boasts first class production technology and highly reliable products.”
“Driven by the high demand of the vaccine industry for vials, expansion of our production capacities is the next logical step,” added Müller-Stauch, in the press release. “We are delighted to have found a strong and reliable partner in DWK who will allow us to further develop our business.”
Source: DWK
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Novartis Acquisition of Regulus Therapeutics is Complete
August 5th 2025A key property included in the acquisition is farabursen, an investigational next-generation oligonucleotide targeting the microRNA miR-17 with preferential kidney exposure, intended to treat people with autosomal dominant polycystic kidney disease.
